please create professional conference poster this is the poster dimensions "Layout and Dimensions: Design your poster in a 16:9 widescreen landscape format (48 cm wide × 27 cm high or 1920 × 1080 pixels). This will help the poster fill the Zoom screen without black sidebars." this si the poster title "Immunopathogenesis-Guided Advanced Therapy in Inflammatory Bowel Disease: Biologics and Small Molecules in the Treat-to-Target Era," Dr. Yousra A. El-Maradny the author, add the most important sections from the pdf in the poster keep it clear, catchy and professional. make the treat to target similar to that in the pdf, keep the drug catrgories and options for ibd and biologics the main centered and most important to present sections. as they are the core of my presentations the biologics nomenclature and history also important. avoid add key message or key points section, add the final section for references
please create professional conference poster this is the poster dimensions "Layout and Dimensions: Design your poster in a 16:9 widescreen landscape
format (48 cm wide × 27 cm high or 1920 × 1080 pixels). This will help the poster
fill the Zoom screen without black sidebars." this si the poster title "Immunopathogenesis-Guided Advanced Therapy in Inflammatory Bowel Disease: Biologics and Small Molecules in the Treat-to-Target Era," Dr. Yousra A. El-Maradny the author, add the most important sections from the pdf in the poster keep it clear, catchy and professional. make the treat to target similar to that in the pdf, keep the drug catrgories and options for ibd and biologics the main centered and most important to present sections. as they are the core of my presentations the biologics nomenclature and history also important. avoid add key message or key points section, add the final section for references
Created using ChatSlide
This presentation covers the immunopathogenesis of Inflammatory Bowel Disease (IBD), emphasizing advanced therapy guided by immunological insights. It discusses the treat-to-target approach, focusing on aligning therapy with disease biology to achieve clinical and biomarker control while preventing structural damage. Additionally, it explores the evolution of biologics in IBD treatment, detailing the transition from anti-TNF therapies to pathway-selective options, and clarifying the...